View in EDS HTML Full Text PDF Full Text

Effect of Esketamine Nasal Spray on Olfactory Function and Nasal Tolerability in Patients with Treatment-Resistant Depression: Results from Four Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Studies.

Saved in:
Bibliographic Details
Title: Effect of Esketamine Nasal Spray on Olfactory Function and Nasal Tolerability in Patients with Treatment-Resistant Depression: Results from Four Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Studies.
Authors: Doty RL; Smell and Taste Center, Department of Otorhinolaryngology: Head and Neck Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Popova V; Janssen Research & Development, Turnhoutseweg 30, 2340, Beerse, BE, Belgium. vpopova@its.jnj.com., Wylie C; Smell and Taste Center, Department of Otorhinolaryngology: Head and Neck Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA., Fedgchin M; Janssen Research & Development, LLC, Titusville, NJ, USA., Daly E; Janssen Scientific Affairs, LLC, Titusville, NJ, USA., Janik A; Janssen Research & Development, LLC, San Diego, CA, USA., Ochs-Ross R; Janssen Research & Development, LLC, Titusville, NJ, USA., Lane R; Janssen Research & Development, LLC, Titusville, NJ, USA., Lim P; Janssen Research & Development, LLC, Titusville, NJ, USA., Cooper K; Janssen Research & Development, LLC, Spring House, PA, USA., Melkote R; Janssen Research & Development, LLC, Titusville, NJ, USA., Jamieson C; Janssen Research & Development, LLC, Milpitas, CA, USA., Singh J; Janssen Research & Development, LLC, San Diego, CA, USA.; Neurocrine Biosciences, San Diego, CA, USA., Drevets WC; Janssen Research & Development, LLC, San Diego, CA, USA.
Source: CNS drugs [CNS Drugs] 2021 Jul; Vol. 35 (7), pp. 781-794. Date of Electronic Publication: 2021 Jul 07.
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9431220 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1934 (Electronic) Linking ISSN: 11727047 NLM ISO Abbreviation: CNS Drugs Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 34235612
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Effect of Esketamine Nasal Spray on Olfactory Function and Nasal Tolerability in Patients with Treatment-Resistant Depression: Results from Four Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Studies.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Doty+RL%22">Doty RL</searchLink>; Smell and Taste Center, Department of Otorhinolaryngology: Head and Neck Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Popova+V%22">Popova V</searchLink>; Janssen Research & Development, Turnhoutseweg 30, 2340, Beerse, BE, Belgium. vpopova@its.jnj.com.<br /><searchLink fieldCode="AU" term="%22Wylie+C%22">Wylie C</searchLink>; Smell and Taste Center, Department of Otorhinolaryngology: Head and Neck Surgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.<br /><searchLink fieldCode="AU" term="%22Fedgchin+M%22">Fedgchin M</searchLink>; Janssen Research & Development, LLC, Titusville, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Daly+E%22">Daly E</searchLink>; Janssen Scientific Affairs, LLC, Titusville, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Janik+A%22">Janik A</searchLink>; Janssen Research & Development, LLC, San Diego, CA, USA.<br /><searchLink fieldCode="AU" term="%22Ochs-Ross+R%22">Ochs-Ross R</searchLink>; Janssen Research & Development, LLC, Titusville, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Lane+R%22">Lane R</searchLink>; Janssen Research & Development, LLC, Titusville, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Lim+P%22">Lim P</searchLink>; Janssen Research & Development, LLC, Titusville, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Cooper+K%22">Cooper K</searchLink>; Janssen Research & Development, LLC, Spring House, PA, USA.<br /><searchLink fieldCode="AU" term="%22Melkote+R%22">Melkote R</searchLink>; Janssen Research & Development, LLC, Titusville, NJ, USA.<br /><searchLink fieldCode="AU" term="%22Jamieson+C%22">Jamieson C</searchLink>; Janssen Research & Development, LLC, Milpitas, CA, USA.<br /><searchLink fieldCode="AU" term="%22Singh+J%22">Singh J</searchLink>; Janssen Research & Development, LLC, San Diego, CA, USA.; Neurocrine Biosciences, San Diego, CA, USA.<br /><searchLink fieldCode="AU" term="%22Drevets+WC%22">Drevets WC</searchLink>; Janssen Research & Development, LLC, San Diego, CA, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229431220%22">CNS drugs</searchLink> [CNS Drugs] 2021 Jul; Vol. 35 (7), pp. 781-794. <i>Date of Electronic Publication: </i>2021 Jul 07.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Adis%2C+Springer+International%22">Adis, Springer International </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>9431220 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1179-1934 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2211727047%22">11727047 </searchLink><i>NLM ISO Abbreviation: </i>CNS Drugs <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34235612
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s40263-021-00826-9
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 781
    Titles:
      – TitleFull: Effect of Esketamine Nasal Spray on Olfactory Function and Nasal Tolerability in Patients with Treatment-Resistant Depression: Results from Four Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III Studies.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Doty RL
      – PersonEntity:
          Name:
            NameFull: Popova V
      – PersonEntity:
          Name:
            NameFull: Wylie C
      – PersonEntity:
          Name:
            NameFull: Fedgchin M
      – PersonEntity:
          Name:
            NameFull: Daly E
      – PersonEntity:
          Name:
            NameFull: Janik A
      – PersonEntity:
          Name:
            NameFull: Ochs-Ross R
      – PersonEntity:
          Name:
            NameFull: Lane R
      – PersonEntity:
          Name:
            NameFull: Lim P
      – PersonEntity:
          Name:
            NameFull: Cooper K
      – PersonEntity:
          Name:
            NameFull: Melkote R
      – PersonEntity:
          Name:
            NameFull: Jamieson C
      – PersonEntity:
          Name:
            NameFull: Singh J
      – PersonEntity:
          Name:
            NameFull: Drevets WC
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2021 Jul
              Type: published
              Y: 2021
          Identifiers:
            – Type: issn-electronic
              Value: 1179-1934
          Numbering:
            – Type: volume
              Value: 35
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: CNS drugs
              Type: main
ResultId 1